About 281.25mg Ceftriaxone And Tazobactam For Injection
Experience world-class infection management with CTSAFE 281.25mg Ceftriaxone and Tazobactam for Injection. Crafted for hospital and professional healthcare use, this single-dose pack brings you the finest blend of Ceftriaxone 250mg and Tazobactam 31.25mg-delivering rapid, crackerjack results against difficult infections. Get robust antibacterial protection, targeting lower respiratory tract, urinary, skin, bone, and joint infections, and more. CTSAFE offers top savings, superb safety, and quick intravenous or intramuscular administration. With a prominent 281.25 label, white and yellow packing, blue flip-off cap, and India origin, it's a trusted hospital essential.
Versatile Application and User-Friendly Administration
CTSAFE 281.25mg Ceftriaxone and Tazobactam for Injection is ideal for hospital use in adults, targeting severe infections such as meningitis, skin infections, and surgical prophylaxis. Administered through intravenous or intramuscular routes, it ensures rapid drug distribution. Key features include a secure blue flip-off cap, clear dosage labeling for professional safety, and powder format for easy preparation. Each vial is designed for single use only, meeting the requirements of busy healthcare settings.
Sample Availability, Secure Shipping, and Prompt Service
CTSAFE 281.25mg injection sample is available for evaluation upon request. Shipped via reputable FOB ports within India, our secure packaging safeguards product integrity during transit. Benefit from quick dispatch with our streamlined order process and flexible payment terms. Each vial is carefully packed in a white and yellow carton, ensuring prompt and safe delivery to hospitals and clinics. Experience reliable service and assured quality with every order.
FAQ's of 281.25mg Ceftriaxone And Tazobactam For Injection:
Q: How should CTSAFE 281.25mg Ceftriaxone and Tazobactam for Injection be administered?
A: CTSAFE 281.25mg should only be administered by a qualified healthcare professional, either intravenously or intramuscularly, as directed by the prescribing physician.
Q: What are the primary medical indications for this injection?
A: This product is indicated for treating lower respiratory tract infections, urinary tract infections, acute bacterial otitis media, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, meningitis, and surgical prophylaxis.
Q: When is CTSAFE most commonly used in clinical practice?
A: CTSAFE is most commonly used in hospitals and clinical settings where prompt, broad-spectrum antibacterial coverage is required, especially for severe or resistant infections.
Q: What is the process for ordering and receiving CTSAFE samples?
A: Samples can be requested through authorized distributors or suppliers. Once the request is approved, samples are promptly dispatched using secure packaging via recognized FOB ports.
Q: What storage recommendations ensure maximum product efficacy?
A: To maintain its efficacy, store CTSAFE injection below 25C and protect it from direct light. Always check the expiry date before use.
Q: Where is this medication manufactured and supplied from?
A: CTSAFE is manufactured and supplied in India by a certified manufacturer, ensuring compliance with stringent pharmaceutical standards.